Matches in Wikidata for { <http://www.wikidata.org/entity/Q91296431> ?p ?o ?g. }
- Q91296431 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91296431 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91296431 description "scientific article published on 29 August 2018" @default.
- Q91296431 description "wetenschappelijk artikel" @default.
- Q91296431 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91296431 name "Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study" @default.
- Q91296431 name "Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study" @default.
- Q91296431 type Item @default.
- Q91296431 label "Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study" @default.
- Q91296431 label "Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study" @default.
- Q91296431 prefLabel "Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study" @default.
- Q91296431 prefLabel "Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study" @default.
- Q91296431 P1433 Q91296431-CF058D08-130C-4144-8C87-27261D2461F5 @default.
- Q91296431 P1476 Q91296431-B12B23FA-B35C-4FD8-80B2-1D3B39427DC3 @default.
- Q91296431 P2093 Q91296431-1401D5D3-0479-4300-8230-0C24B7EFDBB6 @default.
- Q91296431 P2093 Q91296431-2858EE3B-2946-4399-9EF5-3AD12FC6A12A @default.
- Q91296431 P2093 Q91296431-28B4C115-AB1E-4264-8D67-63DE45E99230 @default.
- Q91296431 P2093 Q91296431-2FFDF762-649C-47AB-A385-99B4647F9FB6 @default.
- Q91296431 P2093 Q91296431-308408CA-6689-4A26-A416-D3B1BF470C47 @default.
- Q91296431 P2093 Q91296431-31978484-1E08-445D-96FD-3FC45CAC0BE5 @default.
- Q91296431 P2093 Q91296431-380C7D18-62CC-4F83-958B-699C47549753 @default.
- Q91296431 P2093 Q91296431-3A04E858-9F47-4463-9191-D19D75DB3D07 @default.
- Q91296431 P2093 Q91296431-3E701524-3857-4705-A5EB-EF750485F34D @default.
- Q91296431 P2093 Q91296431-40B05076-D542-4103-A3FD-7F69A00320E7 @default.
- Q91296431 P2093 Q91296431-4EE0F6A8-A44D-4EE2-8547-E31799BFEC14 @default.
- Q91296431 P2093 Q91296431-541D33C2-EDE5-49B0-BA2C-E1B623C18236 @default.
- Q91296431 P2093 Q91296431-57C80C86-591C-452A-BEE2-8F1A4CA3CE64 @default.
- Q91296431 P2093 Q91296431-5F04543A-0829-4247-9975-300BF78D6170 @default.
- Q91296431 P2093 Q91296431-7090491B-6390-4B54-BCA4-F9B94D06740A @default.
- Q91296431 P2093 Q91296431-83280E5A-C367-4352-AEC6-D0639E7ED51D @default.
- Q91296431 P2093 Q91296431-9542AF85-F282-4605-A352-18FD1F254210 @default.
- Q91296431 P2093 Q91296431-976F5E3D-D2F0-4137-9A05-DD19E8F6255D @default.
- Q91296431 P2093 Q91296431-A277F672-717E-4405-8EE3-6B9F9E216D34 @default.
- Q91296431 P2093 Q91296431-A2B75FD8-F05F-45CC-A5EE-630D28A1A121 @default.
- Q91296431 P2093 Q91296431-AC8BC965-D076-47D6-8C6D-AB1DBE2D0710 @default.
- Q91296431 P2093 Q91296431-AD7624B2-606D-4D68-B054-F530E91D60AD @default.
- Q91296431 P2093 Q91296431-AF37C316-D380-4BF2-A3C8-C476991C9307 @default.
- Q91296431 P2093 Q91296431-B318D735-9E98-41CB-AB7C-A9FF395C2339 @default.
- Q91296431 P2093 Q91296431-B7FC6D81-1313-469C-9D75-4648EC02AC6B @default.
- Q91296431 P2093 Q91296431-BD0CB5C5-AE4B-4AEB-B2DC-B1C01C4A6A47 @default.
- Q91296431 P2093 Q91296431-BD90AD97-2E37-4102-A218-76E43111791F @default.
- Q91296431 P2093 Q91296431-BFEF1D9F-4181-4923-BCD2-184D10B270E1 @default.
- Q91296431 P2093 Q91296431-DD929267-730E-43C3-92EA-54286D9D9634 @default.
- Q91296431 P2093 Q91296431-ED0861F3-CFC3-4701-B533-3B1C53FA7919 @default.
- Q91296431 P2093 Q91296431-F457AB73-A42A-4C61-BC99-CA3F460097DC @default.
- Q91296431 P2093 Q91296431-F91C8BF1-4196-46CA-BEAE-F4DC52C1B408 @default.
- Q91296431 P2093 Q91296431-FBA6205C-7F21-4E7F-88F9-3C9B343DFF06 @default.
- Q91296431 P2093 Q91296431-FC33C92B-386A-4476-B872-B9B3BDED281A @default.
- Q91296431 P2093 Q91296431-FEFAED2F-FA15-4646-AAEF-E46521BA2B28 @default.
- Q91296431 P304 Q91296431-80889BD9-6A3A-4434-9810-3850E3B902E1 @default.
- Q91296431 P31 Q91296431-5B29434D-AFFF-42BB-9C61-3DEFB45C40FB @default.
- Q91296431 P433 Q91296431-F0CAE8C4-33EB-4574-9B65-8F2DE264D51D @default.
- Q91296431 P478 Q91296431-EE6B9ACD-52CE-408E-9739-EF62DED20EB7 @default.
- Q91296431 P577 Q91296431-704D97A3-BFB1-4952-929C-D9C1C18B3C59 @default.
- Q91296431 P698 Q91296431-52603643-95A2-4108-84E9-9F45BBD46649 @default.
- Q91296431 P921 Q91296431-54269DD2-3D50-4A81-AB06-E9561891345E @default.
- Q91296431 P921 Q91296431-95E99A19-E0E7-4F51-90A6-5221E079C147 @default.
- Q91296431 P921 Q91296431-B28F9359-07E7-44E3-8A84-EFDAED9BBD9E @default.
- Q91296431 P698 30183595 @default.
- Q91296431 P1433 Q15759225 @default.
- Q91296431 P1476 "Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study" @default.
- Q91296431 P2093 "Bin Zhou" @default.
- Q91296431 P2093 "Chunde Bao" @default.
- Q91296431 P2093 "Dongyi He" @default.
- Q91296431 P2093 "Guochun Wang" @default.
- Q91296431 P2093 "Haiying Chen" @default.
- Q91296431 P2093 "Hao Zhang" @default.
- Q91296431 P2093 "Huaxiang Liu" @default.
- Q91296431 P2093 "Huaxiang Wu" @default.
- Q91296431 P2093 "Hui Song" @default.
- Q91296431 P2093 "Huji Xu" @default.
- Q91296431 P2093 "Jieruo Gu" @default.
- Q91296431 P2093 "Jing Shao" @default.
- Q91296431 P2093 "Jochen Dunkel" @default.
- Q91296431 P2093 "Kristina Harris" @default.
- Q91296431 P2093 "Lan He" @default.
- Q91296431 P2093 "Lindi Jiang" @default.
- Q91296431 P2093 "Lingli Dong" @default.
- Q91296431 P2093 "Liqi Bi" @default.
- Q91296431 P2093 "Marion Boehnlein" @default.
- Q91296431 P2093 "Miaojia Zhang" @default.
- Q91296431 P2093 "Wei Wei" @default.
- Q91296431 P2093 "Xiangpei Li" @default.
- Q91296431 P2093 "Xiangyuan Liu" @default.
- Q91296431 P2093 "Xiaoxia Zuo" @default.
- Q91296431 P2093 "Yi Liu" @default.
- Q91296431 P2093 "Yi Zheng" @default.
- Q91296431 P2093 "Yongfu Wang" @default.
- Q91296431 P2093 "Yuhui Li" @default.
- Q91296431 P2093 "Zhanguo Li" @default.
- Q91296431 P2093 "Zhaoping Lv" @default.
- Q91296431 P2093 "Zhenbiao Wu" @default.
- Q91296431 P2093 "Zhenyu Jiang" @default.
- Q91296431 P2093 "Zhijun Li" @default.
- Q91296431 P2093 "Zhiyi Zhang" @default.
- Q91296431 P2093 "Zhuoli Zhang" @default.
- Q91296431 P304 "227-234" @default.
- Q91296431 P31 Q13442814 @default.
- Q91296431 P433 "2" @default.
- Q91296431 P478 "37" @default.